This investment of around 2 million CHF will allow Medistri to continue providing efficient and reliable sterilization services to a growing client base, with an increase in capacity. The new chamber will be used primarily for the sterilization of pharmaceutical & medical devices coming from multiple countries. It will be fully operational and ready to use by the beginning of 2023.
“We are thrilled to be able to expand our sterilization capabilities with the addition of this new chamber,” said Medistri CEO Shoko Nilforoushan. “This significant investment will enable us to better serve our clients and further our mission of ensuring the safety and quality of sterilized products for customers across Europe.”
Founded in 2006, Medistri has been focused on building infrastructure for the healthcare industry. Companies of every size, from startups & university projects to Fortune 500 companies use our services to save time, scale and focus on what they do best. Medistri reduces the barriers to healthcare product development & scalability. We provide infrastructure for new ventures when they get started and for existing companies to grow globally.
The company is committed to using state-of-the-art technology and following strict sterilization guidelines to ensure the highest level of safety and effectiveness.
- The Medistri Team